메뉴 건너뛰기




Volumn 7, Issue 1, 2004, Pages 79-82

Therapy with biologic agents in SLE

Author keywords

Anti Blys Ab; Anti CD154 Ab; Anti CD20 Ab; Anti IL 10 Ab; Biologic agents; IVIG; LJP 394; SLE

Indexed keywords

ABETIMUS; B N10; BELIMUMAB; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOLOGIC AGENT; INTERLEUKIN 10 ANTIBODY; MONOCLONAL ANTIBODY IDEC 131; OMRIX; PREDNISONE; RITUXIMAB; SANDOZGLOBULIN; STEROID; UNCLASSIFIED DRUG;

EID: 23644453159     PISSN: 02190494     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2004.00067.x     Document Type: Review
Times cited : (3)

References (18)
  • 1
    • 0036252989 scopus 로고    scopus 로고
    • B cell diversity and longevity in systemic autoimmunity
    • Zouali M (2002) B cell diversity and longevity in systemic autoimmunity. Mol Immunol 38, 895-901.
    • (2002) Mol Immunol , vol.38 , pp. 895-901
    • Zouali, M.1
  • 2
    • 0035118621 scopus 로고    scopus 로고
    • Treatment of systemic lupus erythematosus with LJP 394
    • Furie RA, Cash JM, Cronin ME et al. (2001) Treatment of systemic lupus erythematosus with LJP 394. J Rheumatol 28, 257-65.
    • (2001) J Rheumatol , vol.28 , pp. 257-265
    • Furie, R.A.1    Cash, J.M.2    Cronin, M.E.3
  • 3
    • 0037331980 scopus 로고    scopus 로고
    • LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study
    • Alarcon-Segovia D, Tumlin JA, Furie RA et al. (2003) LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum 48, 442-54.
    • (2003) Arthritis Rheum , vol.48 , pp. 442-454
    • Alarcon-Segovia, D.1    Tumlin, J.A.2    Furie, R.A.3
  • 4
    • 0242495115 scopus 로고    scopus 로고
    • Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B Lymphocyte stimulation
    • Baker K, Edwards BM, Main SH et al. (2003) Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B Lymphocyte stimulation. Arthritis Rheum 48, 3253-65.
    • (2003) Arthritis Rheum , vol.48 , pp. 3253-3265
    • Baker, K.1    Edwards, B.M.2    Main, S.H.3
  • 5
    • 0035167632 scopus 로고    scopus 로고
    • Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
    • Zhang J, Roschke V, Baker K et al. (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166, 6-10.
    • (2001) J Immunol , vol.166 , pp. 6-10
    • Zhang, J.1    Roschke, V.2    Baker, K.3
  • 6
    • 0034972257 scopus 로고    scopus 로고
    • Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases
    • Cheema GS, Roschke V, Hilbert DM et al. (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44, 1313-9.
    • (2001) Arthritis Rheum , vol.44 , pp. 1313-1319
    • Cheema, G.S.1    Roschke, V.2    Hilbert, D.M.3
  • 7
    • 0347288173 scopus 로고    scopus 로고
    • BlyS plasma concentrations correlate with disease activity and levels of anti-dsDNA autoantibodies and immunoglobulins (IG) in a SLE observational study
    • Petri M, Stohl W, Chatham W et al. (2003) BlyS plasma concentrations correlate with disease activity and levels of anti-dsDNA autoantibodies and immunoglobulins (IG) in a SLE observational study. Arthritis Rheum 48, S655.
    • (2003) Arthritis Rheum , vol.48
    • Petri, M.1    Stohl, W.2    Chatham, W.3
  • 8
    • 1242314612 scopus 로고    scopus 로고
    • B lymphocyte depletion in the treatment of systemic lupus (SLE): Phase I/II trial of rituximab in SLE
    • Anolik JH, Campbell D, Felgar R et al. (2002) B lymphocyte depletion in the treatment of systemic lupus (SLE): phase I/II trial of rituximab in SLE (Abstract). Arthritis Rheum 46, S717.
    • (2002) Arthritis Rheum , vol.46
    • Anolik, J.H.1    Campbell, D.2    Felgar, R.3
  • 9
    • 0036822286 scopus 로고    scopus 로고
    • An open study of B cell depletion in systemic lupus erythematosus
    • Leandro MJ, Edwards JC, Cambridge G et al. (2002) An open study of B cell depletion in systemic lupus erythematosus. Arthritis Rheum 46, 2673-7.
    • (2002) Arthritis Rheum , vol.46 , pp. 2673-2677
    • Leandro, M.J.1    Edwards, J.C.2    Cambridge, G.3
  • 10
    • 0037638841 scopus 로고    scopus 로고
    • Rituximab therapy and autoimmune disorders
    • Silverman GJ, Weisman S (2003) Rituximab therapy and autoimmune disorders. Arthritis Rheum 48, 1484-92.
    • (2003) Arthritis Rheum , vol.48 , pp. 1484-1492
    • Silverman, G.J.1    Weisman, S.2
  • 11
    • 1542705891 scopus 로고    scopus 로고
    • B cell depletion therapy in systemic lupus erythematosus
    • Anolik J, Sanz I, Looney RJ (2003) B cell depletion therapy in systemic lupus erythematosus. Curr Rheumatol Report 5, 350-6.
    • (2003) Curr Rheumatol Report , vol.5 , pp. 350-356
    • Anolik, J.1    Sanz, I.2    Looney, R.J.3
  • 12
    • 0036899589 scopus 로고    scopus 로고
    • Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154
    • Kalunian KC, Davis JC, Merrill JT et al. (2002) Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154. Arthritis Rheum 46, 3251-8.
    • (2002) Arthritis Rheum , vol.46 , pp. 3251-3258
    • Kalunian, K.C.1    Davis, J.C.2    Merrill, J.T.3
  • 13
    • 0035163042 scopus 로고    scopus 로고
    • Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus
    • Davis JC Jr, Totoritis MC, Rosenberg J et al. (2001) Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus. J Rheumatol 28, 95-101.
    • (2001) J Rheumatol , vol.28 , pp. 95-101
    • Davis Jr., J.C.1    Totoritis, M.C.2    Rosenberg, J.3
  • 14
    • 0034089902 scopus 로고    scopus 로고
    • Novel approaches to therapy for systemic lupus erythematosus
    • Zandman-Goddard G, Shoenfeld Y (2002) Novel approaches to therapy for systemic lupus erythematosus. Eur J Int Med 11, 130-4.
    • (2002) Eur J Int Med , vol.11 , pp. 130-134
    • Zandman-Goddard, G.1    Shoenfeld, Y.2
  • 15
    • 0032728801 scopus 로고    scopus 로고
    • A study of 20 SLE patients with intravenous immunoglobulin - Clinical and serologic response
    • Levy Y, Sherer Y, Ahmed A, Langevitz P et al. (1999) A study of 20 SLE patients with intravenous immunoglobulin - clinical and serologic response. Lupus 8, 705-12.
    • (1999) Lupus , vol.8 , pp. 705-712
    • Levy, Y.1    Sherer, Y.2    Ahmed, A.3    Langevitz, P.4
  • 16
    • 0034098474 scopus 로고    scopus 로고
    • Intravenous immunoglobulin treatment of lupus nephritis
    • Levy Y, Sherer Y, George J et al. (2000) Intravenous immunoglobulin treatment of lupus nephritis. Semin Arthritis Rheum 29, 321-7.
    • (2000) Semin Arthritis Rheum , vol.29 , pp. 321-327
    • Levy, Y.1    Sherer, Y.2    George, J.3
  • 17
    • 0345059308 scopus 로고    scopus 로고
    • Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis
    • Levy Y, Uziel Y, Zandman GG et al. (2003) Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis 62, 1221-3.
    • (2003) Ann Rheum Dis , vol.62 , pp. 1221-1223
    • Levy, Y.1    Uziel, Y.2    Zandman, G.G.3
  • 18
    • 0033883903 scopus 로고    scopus 로고
    • Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
    • Llorente L, Richaud-Patin Y, Garcia-Padilla C et al. (2000) Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43, 1790-80.
    • (2000) Arthritis Rheum , vol.43 , pp. 1790-1880
    • Llorente, L.1    Richaud-Patin, Y.2    Garcia-Padilla, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.